Adar1 Capital Management 13F annual report
Adar1 Capital Management is an investment fund managing more than $495 billion ran by Stephen Scipione. There are currently 224 companies in Mr. Scipione’s portfolio. The largest investments include Protagonist Therapeutics Inc and Cytokinetics Inc, together worth $102 billion.
Limited to 30 biggest holdings
$495 billion Assets Under Management (AUM)
As of 6th August 2024, Adar1 Capital Management’s top holding is 1,603,932 shares of Protagonist Therapeutics Inc currently worth over $55.6 billion and making up 11.2% of the portfolio value.
Relative to the number of outstanding shares of Protagonist Therapeutics Inc, Adar1 Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 853,862 shares of Cytokinetics Inc worth $46.3 billion, whose value fell 27.1% in the past six months.
The third-largest holding is Roivant Sciences Ltd worth $43.9 billion and the next is EA Series Trust worth $37.9 billion, with 351,482 shares owned.
Currently, Adar1 Capital Management's portfolio is worth at least $495 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Adar1 Capital Management
The Adar1 Capital Management office and employees reside in Austin, Texas. According to the last 13-F report filed with the SEC, Stephen Scipione serves as the Chief Compliance Officer at Adar1 Capital Management.
Recent trades
In the most recent 13F filing, Adar1 Capital Management revealed that it had opened a new position in
Rezolute Inc and bought 2,063,962 shares worth $8.88 billion.
The investment fund also strengthened its position in Protagonist Therapeutics Inc by buying
818,277 additional shares.
This makes their stake in Protagonist Therapeutics Inc total 1,603,932 shares worth $55.6 billion.
Protagonist Therapeutics Inc dropped approximately 0.1% in the past year.
On the other hand, there are companies that Adar1 Capital Management is getting rid of from its portfolio.
Adar1 Capital Management closed its position in Merrimack Pharmaceuticals In on 13th August 2024.
It sold the previously owned 902,350 shares for $13.3 billion.
Stephen Scipione also disclosed a decreased stake in Q32 Bio Inc by 0.2%.
This leaves the value of the investment at $2.81 billion and 156,504 shares.
One of the average hedge funds
The two most similar investment funds to Adar1 Capital Management are Barber and Engine Capital Management, L.P.. They manage $495 billion and $495 billion respectively.
Stephen Scipione investment strategy
Adar1 Capital Management’s portfolio is diversified across 10 sectors.
Currently, their heaviest sector is Health Care — making up 59.9% of
the total portfolio value.
The fund focuses on investments in the United States as
45.5% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
12% of the total holdings value.
On the other hand, large-cap stocks make up only 4.0% of the portfolio.
The average market cap of the portfolio companies is close to $7.65 billion.
The complete list of Adar1 Capital Management trades based on 13F SEC filings
These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Protagonist Therapeutics Inc |
104.15%
1,603,932
|
$55,576,244,000 | 11.23% |
| Cytokinetics Inc |
167.24%
853,862
|
$46,262,243,000 | 9.35% |
| Roivant Sciences Ltd |
48.65%
4,150,009
|
$43,865,595,000 | 8.86% |
| EA Series Trust |
10.49%
351,482
|
$37,895,032,000 | 7.66% |
| BridgeBio Pharma Inc |
130.00%
1,264,570
|
$32,031,558,000 | 6.47% |
| Royalty Pharma plc |
63.78%
1,181,332
|
$31,151,725,000 | 6.29% |
| Keros Therapeutics, Inc. |
62.28%
548,916
|
$25,085,461,000 | 5.07% |
| Merrimack Pharmaceuticals In |
Closed
902,350
|
$13,327,710,000 | |
| Immunovant Inc |
684.27%
476,543
|
$12,580,735,000 | 2.54% |
| Arbutus Biopharma Corp |
58.58%
3,289,260
|
$10,163,813,000 | 2.05% |
| Merck Co Inc |
25,150.00%
75,750
|
$9,377,850,000 | 1.89% |
| Rezolute Inc |
Opened
2,063,962
|
$8,875,037,000 | 1.79% |
| Solid Biosciences Inc |
599.01%
1,420,422
|
$8,053,793,000 | 1.63% |
| Edgewise Therapeutics Inc |
141.34%
436,608
|
$7,863,310,000 | 1.59% |
| Perceptive Cap Solutions Cor |
Opened
750,000
|
$7,545,000,000 | 1.52% |
| Ascendis Pharma A/S |
5.51%
51,263
|
$6,991,248,000 | 1.41% |
| Tectonic Therapeutic Inc |
Opened
356,878
|
$5,877,781,000 | 1.19% |
| Uniqure Nv |
317.51%
1,222,676
|
$5,477,588,000 | 1.11% |
| Absci Corporation |
189.37%
1,698,529
|
$5,231,469,000 | 1.06% |
| AvroBio Inc |
Closed
3,954,857
|
$5,062,217,000 | |
| Viking Therapeutics Inc |
533.48%
91,227
|
$4,835,943,000 | 0.98% |
| Alkermes plc |
25.53%
196,577
|
$4,737,506,000 | 0.96% |
| Helix Acquisition Corp Ii |
0.16%
404,138
|
$4,130,290,000 | 0.83% |
| AnaptysBio Inc |
15,479.90%
155,799
|
$3,904,323,000 | 0.79% |
| Cerevel Therapeutics Hldng I |
284.81%
93,350
|
$3,817,082,000 | 0.77% |
| Fusion Pharmaceuticals Inc. |
Closed
177,200
|
$3,777,904,000 | |
| Crinetics Pharmaceuticals In |
Opened
74,850
|
$3,352,532,000 | 0.68% |
| Spdr Ser Tr |
No change
32,500
|
$2,982,850,000 | 0.60% |
| Insmed Inc |
Opened
42,217
|
$2,828,539,000 | 0.57% |
| Q32 Bio Inc |
16.56%
156,504
|
$2,809,247,000 | 0.57% |
| Acasti Pharma Inc |
341.42%
959,571
|
$2,801,947,000 | 0.57% |
| Vanguard Bd Index Fds |
No change
55,206
|
$2,733,801,000 | 0.55% |
| J P Morgan Exchange Traded F |
No change
54,000
|
$2,725,380,000 | 0.55% |
| Ishares Tr |
No change
26,500
|
$2,890,810,000 | 0.58% |
| Savara Inc |
11,749.96%
663,598
|
$2,674,300,000 | 0.54% |
| Omniab Inc |
57.83%
712,560
|
$2,672,100,000 | 0.54% |
| Wisdomtree Tr |
No change
53,000
|
$2,666,430,000 | 0.54% |
| Achieve Life Sciences Inc. |
38.03%
542,233
|
$2,548,495,000 | 0.51% |
| Centessa Pharmaceuticals Plc |
22.40%
253,197
|
$2,286,369,000 | 0.46% |
| Fulcrum Therapeutics Inc |
8.40%
368,369
|
$2,283,888,000 | 0.46% |
| Regeneron Pharmaceuticals, Inc. |
Closed
2,300
|
$2,213,727,000 | |
| Kala Bio Inc. |
Opened
306,067
|
$2,170,015,000 | 0.44% |
| Kiniksa Pharmaceuticals Intl |
Opened
114,309
|
$2,134,149,000 | 0.43% |
| Ssga Active Etf Tr |
No change
47,684
|
$1,929,771,000 | 0.39% |
| Schrodinger, Inc. |
Closed
63,586
|
$1,716,822,000 | |
| Beam Therapeutics Inc. |
Opened
72,800
|
$1,705,704,000 | 0.34% |
| Cellectar Biosciences Inc |
6.16%
682,094
|
$1,705,235,000 | 0.34% |
| Teva Pharmaceutical Inds Ltd |
1.47%
103,121
|
$1,675,716,000 | 0.34% |
| Delcath Sys Inc |
9.42%
198,347
|
$1,660,164,000 | 0.34% |
| Soleno Therapeutics Inc |
Opened
39,929
|
$1,629,103,000 | 0.33% |
| Apogee Therapeutics Inc |
581.25%
40,875
|
$1,608,431,000 | 0.33% |
| Merus N.V |
Opened
26,850
|
$1,588,714,000 | 0.32% |
| BeiGene Ltd |
64.77%
11,100
|
$1,583,637,000 | 0.32% |
| Aura Biosciences Inc |
Opened
203,237
|
$1,536,472,000 | 0.31% |
| Kymera Therapeutics, Inc. |
216.41%
50,626
|
$1,511,186,000 | 0.31% |
| Applied Therapeutics, Inc. |
29.76%
320,727
|
$1,497,795,000 | 0.30% |
| Eli Lilly Co |
Closed
1,865
|
$1,450,895,000 | |
| Ngm Biopharmaceuticals Inc |
Closed
816,581
|
$1,298,364,000 | |
| Context Therapeutics Inc |
213.29%
645,161
|
$1,293,548,000 | 0.26% |
| Astria Therapeutics Inc |
2,869.86%
138,158
|
$1,257,238,000 | 0.25% |
| iBio Inc |
5.00%
570,000
|
$1,202,700,000 | 0.24% |
| Spero Therapeutics Inc |
0.86%
918,929
|
$1,194,608,000 | 0.24% |
| Kiniksa Pharmaceuticals International Plc. |
Closed
59,700
|
$1,177,881,000 | |
| Indivior Plc |
153.64%
70,007
|
$1,128,513,000 | 0.23% |
| Pfizer Inc. |
62.43%
39,950
|
$1,117,801,000 | 0.23% |
| Envveno Medical Corporation |
No change
201,728
|
$1,059,072,000 | 0.21% |
| Target Hospitality Corp. |
Opened
113,626
|
$989,682,000 | 0.20% |
| Guardant Health Inc |
100.00%
34,000
|
$981,920,000 | 0.20% |
| Vir Biotechnology Inc |
Opened
110,000
|
$979,000,000 | 0.20% |
| Cullinan Therapeutics Inc |
Opened
53,261
|
$928,872,000 | 0.19% |
| Vaxcyte, Inc. |
512.50%
12,250
|
$924,998,000 | 0.19% |
| iTeos Therapeutics, Inc. |
Opened
60,000
|
$890,400,000 | 0.18% |
| Alector, Inc. |
272.02%
195,311
|
$886,712,000 | 0.18% |
| Denali Therapeutics Inc |
1,800.00%
38,000
|
$882,360,000 | 0.18% |
| Angiodynamics Inc |
6.19%
143,862
|
$870,365,000 | 0.18% |
| Arvinas Inc |
23.66%
32,400
|
$862,488,000 | 0.17% |
| Global Star Acquisition Inc |
Closed
80,000
|
$856,800,000 | |
| Spyre Therapeutics Inc |
28.93%
35,180
|
$827,082,000 | 0.17% |
| Avangrid Inc |
Opened
23,000
|
$817,190,000 | 0.17% |
| Perspective Therapeutics Inc |
Closed
676,725
|
$805,303,000 | |
| Apellis Pharmaceuticals Inc |
19.65%
20,650
|
$792,134,000 | 0.16% |
| Kiora Pharmaceuticals Inc |
Closed
1,100,000
|
$776,600,000 | |
| Silence Therapeutics plc |
0.50%
40,290
|
$765,510,000 | 0.15% |
| Kiora Pharmaceuticals Inc |
Opened
172,596
|
$724,903,000 | 0.15% |
| Sarepta Therapeutics Inc |
85.69%
4,450
|
$703,100,000 | 0.14% |
| CytomX Therapeutics Inc |
269.14%
572,170
|
$698,047,000 | 0.14% |
| Perspective Therapeutics Inc |
Opened
69,985
|
$697,750,000 | 0.14% |
| Eliem Therapeutics Inc |
Opened
97,695
|
$694,611,000 | 0.14% |
| Morphic Hldg Inc |
Closed
19,701
|
$693,475,000 | |
| Beyond Air, Inc. |
1.70%
1,225,270
|
$658,338,000 | 0.13% |
| Kezar Life Sciences Inc |
359.17%
1,086,498
|
$651,899,000 | 0.13% |
| Vaxart Inc |
Opened
945,568
|
$630,978,000 | 0.13% |
| Corteva Inc |
69.52%
11,400
|
$614,916,000 | 0.12% |
| Arya Sciences Acqu Corp Iv |
30.78%
53,527
|
$613,955,000 | 0.12% |
| Akero Therapeutics Inc |
1,311.57%
25,507
|
$598,394,000 | 0.12% |
| Taysha Gene Therapies, Inc. |
476.55%
250,800
|
$561,792,000 | 0.11% |
| Actinium Pharmaceuticals Inc |
24.87%
75,133
|
$555,984,000 | 0.11% |
| Tmt Acquisition Corp |
No change
50,000
|
$549,000,000 | 0.11% |
| Corbus Pharmaceuticals Hldgs |
25.00%
12,000
|
$543,000,000 | 0.11% |
| Rhythm Pharmaceuticals Inc. |
4.84%
13,000
|
$533,780,000 | 0.11% |
| Ardelyx Inc |
Opened
70,000
|
$518,700,000 | 0.10% |
| AB Active ETFs Inc |
No change
10,000
|
$505,150,000 | 0.10% |
| Pgim Etf Tr |
No change
10,000
|
$497,000,000 | 0.10% |
| Stevanato Group S.p.A. |
74.19%
27,000
|
$495,180,000 | 0.10% |
| Day One Biopharmaceuticals I |
Opened
35,100
|
$483,678,000 | 0.10% |
| Gossamer Bio, Inc. |
27.30%
532,628
|
$479,845,000 | 0.10% |
| Abeona Therapeutics Inc |
Opened
113,125
|
$479,650,000 | 0.10% |
| Vistagen Therapeutics Inc. |
Closed
89,938
|
$474,873,000 | |
| Alnylam Pharmaceuticals Inc |
98.97%
1,850
|
$449,550,000 | 0.09% |
| PolyPid Ltd. |
Opened
103,950
|
$446,985,000 | 0.09% |
| Sanofi |
65.45%
9,100
|
$441,532,000 | 0.09% |
| TherapeuticsMD, Inc. |
0.73%
270,160
|
$434,958,000 | 0.09% |
| Aerovate Therapeutics Inc |
1,453.06%
246,936
|
$409,914,000 | 0.08% |
| Cg Oncology Inc |
526.83%
12,850
|
$405,674,000 | 0.08% |
| Renovorx Inc |
Opened
355,240
|
$401,421,000 | 0.08% |
| TripAdvisor Inc. |
Opened
22,000
|
$391,820,000 | 0.08% |
| Movano Inc |
Opened
1,407,000
|
$386,925,000 | 0.08% |
| Wave Life Sciences Ltd. |
155.50%
76,651
|
$382,488,000 | 0.08% |
| Geron Corp. |
6,849.81%
90,000
|
$381,600,000 | 0.08% |
| Zai Lab Ltd |
No change
22,000
|
$381,260,000 | 0.08% |
| Bicycle Therapeutics plc |
Closed
14,430
|
$359,307,000 | |
| Abivax Sa |
80.00%
27,000
|
$356,940,000 | 0.07% |
| Abbott Labs |
135.71%
3,300
|
$342,903,000 | 0.07% |
| VYNE Therapeutics Inc. |
55.52%
171,217
|
$337,297,000 | 0.07% |
| Option Care Health, Inc. |
71.43%
12,000
|
$332,400,000 | 0.07% |
| Janux Therapeutics Inc |
43.64%
7,891
|
$330,554,000 | 0.07% |
| Grail Inc |
Opened
21,401
|
$328,933,000 | 0.07% |
| Oak Woods Acquisition Corp |
No change
30,000
|
$326,400,000 | 0.07% |
| ARCA biopharma Inc |
Opened
84,676
|
$324,309,000 | 0.07% |
| Screaming Eagle Acquisitn Co |
Closed
30,000
|
$321,000,000 | |
| Alphabet Inc |
Closed
2,000
|
$301,860,000 | |
| Mineralys Therapeutics Inc |
5.69%
25,366
|
$296,782,000 | 0.06% |
| West Pharmaceutical Svsc Inc |
40.67%
890
|
$293,157,000 | 0.06% |
| Endeavor Group Hldgs Inc |
93.16%
10,615
|
$286,923,000 | 0.06% |
| Tourmaline Bio Inc |
82.18%
21,060
|
$270,832,000 | 0.05% |
| Milestone Pharmaceuticals In |
No change
202,460
|
$267,247,000 | 0.05% |
| Mks Instrs Inc |
Opened
2,000
|
$261,160,000 | 0.05% |
| Korro Bio Inc |
Opened
7,210
|
$244,203,000 | 0.05% |
| Veru Inc |
Closed
336,072
|
$235,284,000 | |
| Elevation Oncology Inc |
884.20%
84,927
|
$229,303,000 | 0.05% |
| Cogent Communications Hldgs |
No change
4,000
|
$225,760,000 | 0.05% |
| Pimco Etf Tr |
No change
3,000
|
$225,270,000 | 0.05% |
| Ocular Therapeutix Inc |
Opened
32,900
|
$225,036,000 | 0.05% |
| Acelyrin Inc |
236.34%
50,521
|
$222,798,000 | 0.05% |
| Olema Pharmaceuticals, Inc. |
Opened
20,076
|
$217,222,000 | 0.04% |
| Verve Therapeutics Inc |
Opened
44,000
|
$214,720,000 | 0.04% |
| Moonlake Immunotherapeutics |
60.00%
4,800
|
$211,056,000 | 0.04% |
| Intelligent Bio Solutions In |
No change
108,250
|
$207,840,000 | 0.04% |
| Amylyx Pharmaceuticals Inc |
176.15%
107,306
|
$203,881,000 | 0.04% |
| Mereo BioPharma Group plc |
Opened
55,400
|
$199,440,000 | 0.04% |
| Spruce Biosciences, Inc. |
2.74%
355,216
|
$183,895,000 | 0.04% |
| Xenon Pharmaceuticals Inc |
Opened
4,700
|
$183,253,000 | 0.04% |
| Biocryst Pharmaceuticals Inc. |
Opened
29,400
|
$181,692,000 | 0.04% |
| Iovance Biotherapeutics Inc |
348.00%
22,400
|
$179,648,000 | 0.04% |
| Immatics N.v |
Closed
16,200
|
$170,262,000 | |
| Greenlight Capital Re Ltd |
7.47%
12,385
|
$162,244,000 | 0.03% |
| Nuvei Corporation |
No change
5,000
|
$161,900,000 | 0.03% |
| Chimerix Inc |
Opened
178,229
|
$156,129,000 | 0.03% |
| Arrowhead Pharmaceuticals In |
883.33%
5,900
|
$153,341,000 | 0.03% |
| Cabaletta Bio Inc |
Closed
8,900
|
$151,834,000 | |
| Relmada Therapeutics Inc |
8,319.47%
50,601
|
$151,803,000 | 0.03% |
| Voyager Therapeutics Inc |
79.64%
18,634
|
$147,395,000 | 0.03% |
| KalVista Pharmaceuticals Inc |
20.20%
12,020
|
$141,596,000 | 0.03% |
| Nextcure Inc |
106.94%
89,014
|
$141,532,000 | 0.03% |
| Pasithea Therapeutics Corp |
No change
27,696
|
$140,161,000 | 0.03% |
| Bolt Biotherapeutics Inc |
3,619.98%
185,999
|
$139,499,000 | 0.03% |
| Mckesson Corporation |
Closed
250
|
$134,212,000 | |
| Avalo Therapeutics Inc |
Closed
6,000
|
$130,500,000 | |
| Prothena Corp Plc |
No change
5,988
|
$123,592,000 | 0.02% |
| Eagle Pharmaceuticals Inc |
Opened
22,000
|
$123,200,000 | 0.02% |
| JD.com Inc |
Closed
4,000
|
$109,560,000 | |
| Pliant Therapeutics, Inc. |
Opened
10,000
|
$107,500,000 | 0.02% |
| Four Leaf Acquisition Corp |
Closed
10,000
|
$107,200,000 | |
| Viridian Therapeutics Inc |
213.73%
8,000
|
$104,080,000 | 0.02% |
| Terns Pharmaceuticals Inc |
200.00%
15,000
|
$102,150,000 | 0.02% |
| Scholar Rock Hldg Corp |
Opened
12,000
|
$99,960,000 | 0.02% |
| TG Therapeutics Inc |
28.16%
5,589
|
$99,428,000 | 0.02% |
| Longboard Pharmaceuticals In |
Closed
4,580
|
$98,928,000 | |
| Equillium Inc |
29.18%
140,775
|
$97,585,000 | 0.02% |
| Kensington Capital Acquisiti |
5.56%
8,500
|
$94,222,000 | 0.02% |
| Bausch Plus Lomb Corp |
20.75%
6,400
|
$92,928,000 | 0.02% |
| Algonquin Pwr Utils Corp |
59.46%
15,000
|
$87,900,000 | 0.02% |
| Altria Group Inc. |
Closed
2,000
|
$87,240,000 | |
| Forte Biosciences, Inc. |
6.60%
159,258
|
$85,522,000 | 0.02% |
| Pmv Pharmaceuticals Inc |
400.00%
50,000
|
$81,000,000 | 0.02% |
| Adverum Biotechnologies Inc |
303.57%
11,300
|
$77,518,000 | 0.02% |
| Ikena Oncology Inc |
33.39%
46,685
|
$77,030,000 | 0.02% |
| Ligand Pharmaceuticals, Inc. |
96.68%
890
|
$74,991,000 | 0.02% |
| Adicet Bio Inc |
Closed
31,229
|
$73,388,000 | |
| Nurix Therapeutics, Inc. |
90.17%
3,500
|
$73,045,000 | 0.01% |
| Ionis Pharmaceuticals Inc |
48.28%
1,500
|
$71,490,000 | 0.01% |
| Jasper Therapeutics Inc |
Closed
2,406
|
$70,640,000 | |
| Quince Therapeutics Inc |
246.48%
92,958
|
$69,718,000 | 0.01% |
| Howard Hughes Corporation |
No change
1,000
|
$64,820,000 | 0.01% |
| VanEck ETF Trust |
Closed
2,000
|
$63,240,000 | |
| Mitek Sys Inc |
No change
5,600
|
$62,608,000 | 0.01% |
| Lantheus Holdings Inc |
Closed
1,000
|
$62,240,000 | |
| Structure Therapeutics Inc |
39.36%
1,516
|
$59,533,000 | 0.01% |
| Disc Medicine Inc |
Closed
896
|
$55,785,000 | |
| Krystal Biotech Inc |
Closed
300
|
$53,379,000 | |
| KraneShares Trust |
Closed
2,000
|
$52,500,000 | |
| Organon Co |
58.33%
2,500
|
$51,750,000 | 0.01% |
| FibroGen Inc |
Closed
21,350
|
$50,172,000 | |
| Ultra Clean Hldgs Inc |
No change
1,000
|
$49,000,000 | 0.01% |
| Kohls Corp |
No change
2,000
|
$45,980,000 | 0.01% |
| Neurogene Inc |
89.56%
1,253
|
$45,597,000 | 0.01% |
| CASI Pharmaceuticals Inc |
Opened
8,240
|
$45,320,000 | 0.01% |
| Evotec Ag |
22.08%
9,400
|
$45,120,000 | 0.01% |
| 89bio Inc |
81.70%
5,560
|
$44,536,000 | 0.01% |
| 4d Molecular Therapeutics In |
No change
2,000
|
$41,980,000 | 0.01% |
| Cara Therapeutics Inc |
Opened
159,469
|
$41,143,000 | 0.01% |
| Stoke Therapeutics, Inc. |
Closed
2,900
|
$39,150,000 | |
| MagnaChip Semiconductor Corp |
Closed
7,000
|
$39,060,000 | |
| Vera Therapeutics Inc |
Opened
1,079
|
$39,038,000 | 0.01% |
| IGM Biosciences, Inc. |
Closed
4,000
|
$38,600,000 | |
| GlycoMimetics Inc |
Opened
135,000
|
$38,016,000 | 0.01% |
| Pharvaris N V |
No change
2,000
|
$37,600,000 | 0.01% |
| ASLAN Pharmaceuticals Ltd |
Closed
59,393
|
$36,539,000 | |
| Zyversa Therapeutics Inc |
Opened
9,598
|
$36,088,000 | 0.01% |
| Hookipa Pharma Inc |
Closed
50,000
|
$35,600,000 | |
| Pyxis Oncology Inc |
No change
10,000
|
$33,100,000 | 0.01% |
| Regenxbio Inc |
8.00%
2,700
|
$31,590,000 | 0.01% |
| Ventyx Biosciences Inc |
159.10%
12,955
|
$29,926,000 | 0.01% |
| Liquidia Corp |
Closed
2,000
|
$29,500,000 | |
| Design Therapeutics Inc |
Closed
7,200
|
$29,016,000 | |
| Novo-nordisk A S |
100.00%
200
|
$28,548,000 | 0.01% |
| Perrigo Co Plc |
37.50%
1,100
|
$28,248,000 | 0.01% |
| Amphastar Pharmaceuticals In |
No change
700
|
$28,000,000 | 0.01% |
| Ncr Atleos Corporation |
No change
1,000
|
$27,020,000 | 0.01% |
| Exact Sciences Corp. |
64.71%
600
|
$25,350,000 | 0.01% |
| Ncr Voyix Corporation |
No change
2,000
|
$24,700,000 | 0.00% |
| Axsome Therapeutics Inc |
Opened
300
|
$24,150,000 | 0.00% |
| Celcuity Inc |
Opened
1,400
|
$22,932,000 | 0.00% |
| RAPT Therapeutics, Inc. |
Opened
7,500
|
$22,875,000 | 0.00% |
| Oncternal Therapeutics, Inc. |
Closed
2,472
|
$22,248,000 | |
| Gh Research Plc |
85.30%
1,850
|
$21,571,000 | 0.00% |
| Acadia Pharmaceuticals Inc |
160.00%
1,300
|
$21,125,000 | 0.00% |
| Lexeo Therapeutics Inc |
Opened
1,300
|
$20,852,000 | 0.00% |
| Compass Therapeutics Inc |
Closed
10,206
|
$20,208,000 | |
| Zymeworks Inc |
Closed
1,900
|
$19,988,000 | |
| Amplify Energy Corp. |
58.65%
2,928
|
$19,852,000 | 0.00% |
| Hims Hers Health Inc |
Opened
940
|
$18,979,000 | 0.00% |
| PureTech Health plc |
Opened
700
|
$17,500,000 | 0.00% |
| Rallybio Corp |
37.58%
11,200
|
$15,008,000 | 0.00% |
| Ovid Therapeutics Inc |
16.68%
19,190
|
$14,761,000 | 0.00% |
| Arcutis Biotherapeutics Inc |
63.45%
1,555
|
$14,462,000 | 0.00% |
| Steel Partners Hldgs L P |
Closed
341
|
$13,521,000 | |
| Celldex Therapeutics Inc. |
Opened
303
|
$11,214,000 | 0.00% |
| Biohaven Ltd |
Closed
200
|
$10,938,000 | |
| IDEAYA Biosciences, Inc. |
Opened
300
|
$10,533,000 | 0.00% |
| Aurinia Pharmaceuticals Inc |
Closed
2,000
|
$10,020,000 | |
| Zevra Therapeutics Inc |
Opened
2,000
|
$9,800,000 | 0.00% |
| Maravai Lifesciences Hldgs I |
Closed
1,000
|
$8,670,000 | |
| Oklo Inc |
Opened
1,000
|
$8,470,000 | 0.00% |
| Dyne Therapeutics, Inc. |
Closed
297
|
$8,432,000 | |
| Protara Therapeutics Inc |
Closed
2,000
|
$8,020,000 | |
| Astrazeneca plc |
50.00%
100
|
$7,799,000 | 0.00% |
| Addex Therapeutics Ltd |
130.77%
900
|
$7,398,000 | 0.00% |
| Erasca Inc |
Opened
3,100
|
$7,316,000 | 0.00% |
| Surrozen Inc |
Closed
450
|
$7,070,000 | |
| Bluebird bio Inc |
20.00%
6,000
|
$5,905,000 | 0.00% |
| Engene Holdings Inc |
Opened
600
|
$5,658,000 | 0.00% |
| Arcellx Inc |
Opened
100
|
$5,519,000 | 0.00% |
| Tyra Biosciences Inc |
98.94%
300
|
$4,797,000 | 0.00% |
| Masimo Corp |
No change
38
|
$4,786,000 | 0.00% |
| Beyond Meat Inc |
Closed
577
|
$4,778,000 | |
| Ichor Holdings Ltd |
No change
108
|
$4,163,000 | 0.00% |
| Eton Pharmaceuticals, Inc. |
Opened
1,200
|
$3,948,000 | 0.00% |
| 2seventy Bio Inc |
No change
1,000
|
$3,850,000 | 0.00% |
| Calcimedica Inc |
Closed
781
|
$3,249,000 | |
| OptiNose Inc |
Opened
3,000
|
$3,120,000 | 0.00% |
| Lexaria Bioscience Corp |
96.45%
945
|
$2,627,000 | 0.00% |
| Talis Biomedical Corp |
Closed
300
|
$2,625,000 | |
| Thunder Pwr Hldgs Inc |
90.00%
1,500
|
$2,475,000 | 0.00% |
| Xeris Biopharma Holdings Inc |
80.58%
1,000
|
$2,250,000 | 0.00% |
| Karyopharm Therapeutics Inc |
Closed
1,479
|
$2,233,000 | |
| Rocket Pharmaceuticals Inc |
Opened
100
|
$2,153,000 | 0.00% |
| Xilio Therapeutics Inc |
Opened
1,500
|
$1,421,000 | 0.00% |
| Travere Therapeutics Inc |
Closed
100
|
$771,000 | |
| No transactions found | |||
| Showing first 500 out of 279 holdings | |||
Hedge funds similar to Adar1 Capital Management
- Bioimpact Capital
- Advocate Group
- Advisors Network
- Ipg Investment Advisors
- Pertento Partners LL.P.
- Glynn Capital Management
- Engine Capital Management, L.P.
- Barber
- Bedel Financial Consulting Inc
- Pettyjohn, Wood & White, Inc
- Sugarloaf Wealth Management
- Summit Wealth Advisors
- Chicago Trust Co Na
- Chandler Asset Management